Venezuela will use “convalescent plasma”, which consists of blood transfusions from patients already recovered from COVID-19, for the treatment of new carriers.
The announcement was made by the Executive Vice President of the Republic, Delcy Rodríguez, who highlighted the effectiveness of this therapeutic scheme, after an exhaustive review of the sanitary protocols adopted worldwide.
“It has had a good impact in most of the countries where it has been applied, and we are also going to start this treatment scheme in Venezuela”, she stated from the headquarters of the Vice Presidency of the Republic, located in Caracas.
The therapy with “convalescent plasma”, effectively applied in the treatment of respiratory viruses, is about blood transfusions from recovered patients, since they develop antibodies that can be used to fight the infectious disease.
Amidst the COVID-19 pandemic, Chinese health authorities have conducted studies confirming the positive results of plasma transplants from people who have already overcome the infection.
Permanent surveillance in Zulia state:
In a dialogue with the President of the Republic, Nicolás Maduro, Rodríguez stressed that the Presidential Commission for Monitoring, Control and Prevention of COVID-19, continues epidemiological surveillance in Zulia state, as a result of the outbreak registered in the Las Pulgas Market in Maracaibo, that “has even had a projection in other states”.
